Top Stories
Proposed venture with Memorial Sloan Kettering would move beyond licensed assays, using MSK oncology data and SOPHiA DDM to develop new diagnostics and companion tools.
In addition to Chai-3, the drugmaker will have access to a bespoke AI model designed specifically for its own workflows.
Designed to operate with minimal user interaction, MIM Contour ProtégéAI+ 2.0 automatically initiates contouring.
The results come a week after Noom rolled out its at-home test kit evaluating 17 biomarkers across cardiovascular, metabolic, hormonal, inflammatory and nutritional health.
The update adds compatibility with Abbott’s FreeStyle Libre 3 Plus sensor to Omnipod 5 and introduces a 100 mg/dL glucose target for automated insulin delivery.
Conference News
Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance New data expands on findings s...
Dexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin around the world.Showed use of Dexcom ...
New Study Highlights Potential of CGM to Help Patients Improve Diabetes Management in Primary Care SettingsNEW ORLEANS, June 6, 2026 /PRNewswire/ -- A new study examining the role of continuous glucos...
Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and del...
STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes typesEVOLUTION 3 feasibility study demonstrates improved time in range using a...
